Joint with: HIV Vaccines: Intersections of Basic and Clinical Science
Decoding HIV Persistence: Strategies for Curing HIV Infection
January 1-4, 2026 | Location to be Determined
Scientific Organizers:
Mathias Lichterfeld, Afam Okoye, Marina F. Caskey and Caroline T. Tiemessen
In Person
On Demand
January 1-4, 2026 | Location to be Determined
Scientific Organizers:
Mathias Lichterfeld, Afam Okoye, Marina F. Caskey and Caroline T. Tiemessen
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Thursday, January 1, 2026
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Friday, January 2, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address (Joint)
8:00–9:00 AM
Alexandra Trkola †, University of Zürich
HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure
HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure
Immune Interventions Interfacing HIV Prevention and Cure (Joint)
9:00–11:15 AM
Drew Weissman †, University of Pennsylvania
mRNA-Based Approaches for Manipulating HIV Reservoirs and Immune Responses
mRNA-Based Approaches for Manipulating HIV Reservoirs and Immune Responses
Beatriz Mothe Pujadas †, IrsiCaixa and Germans Trias i Pujol University Hospital
Therapeutic Vaccination for Inducing Sustained HIV Immune Control
Therapeutic Vaccination for Inducing Sustained HIV Immune Control
Leonidas Stamatatos †, Fred Hutchinson Cancer Research Center
Vaccination of PLWH, using 426C Derived Immunogens
Vaccination of PLWH, using 426C Derived Immunogens
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
On Own for Lunch
11:15–5:00 PM
Poster Setup
11:15–1:00 PM
Poster Viewing
1:00–10:00 PM
Coffee Available
4:30–5:00 PM
Immune Targeting of HIV-1 Reservoir Cells: Obstacles and Opportunities
5:00–6:45 PM
Brad Jones †, Weill Cornell Medicine
HIV Reservoir Cell Resistance to Immune-Mediated Killing
HIV Reservoir Cell Resistance to Immune-Mediated Killing
Michel C. Nussenzweig †, HHMI/Rockefeller University
Viral Reservoir Dynamics in the RIO Clinical Trial
Viral Reservoir Dynamics in the RIO Clinical Trial
Kiera L. Clayton †, University of Massachusetts Medical School
NK Cell Targeting of the HIV Reservoir
NK Cell Targeting of the HIV Reservoir
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Saturday, January 3, 2026
Breakfast
7:00–8:00 AM
Tailoring Gene- and Cell-Therapy Approaches for HIV Cure: Promises and Pitfalls
8:00–11:00 AM
Afam Okoye, Oregon Health & Science University
Optimizing T Cell Responses for Post-ART Control
Optimizing T Cell Responses for Post-ART Control
James L. Riley †, University of Pennsylvania
Immune-Based Cell Therapies
Immune-Based Cell Therapies
Lydie Trautmann †, Military HIV Research Program
Therapeutic Vaccine Trials in Humans
Therapeutic Vaccine Trials in Humans
Daniel Dornbusch †, Excision Bio Inc.
CRISPR for HIV Cure: Human Clinical Trial Data
CRISPR for HIV Cure: Human Clinical Trial Data
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable (Joint)
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Mechanisms of HIV Persistence: Insights and Innovations
5:00–7:00 PM
Mathias Lichterfeld, Brigham and Women's Hospital
Epigenetic Mechanisms of HIV Persistence
Epigenetic Mechanisms of HIV Persistence
Florence Margottin †, Institut Cochin de Genetique Moleculaire
HIV Latency and the HUSH Complex
HIV Latency and the HUSH Complex
Frauke Mücksch †, Heidelberg University Hospital
Mechanisms of HIV Latency in Cell Clones with Distinct Integration Sites
Mechanisms of HIV Latency in Cell Clones with Distinct Integration Sites
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Sunday, January 4, 2026
Breakfast
7:00–8:00 AM
No One Left Behind: HIV Cure Research Across the Age Continuum
8:00–11:00 AM
Caroline T. Tiemessen, National Institute for Communicable Diseases
HIV Immune Responses Across the Age Spectrum
HIV Immune Responses Across the Age Spectrum
Deborah Persaud †, Johns Hopkins University School of Medicine
HIV Remission in Infants
HIV Remission in Infants
Roger Shapiro †, Harvard School of Public Health
Triple Combinations of Broadly-Neutralizing Antibodies in Infants
Triple Combinations of Broadly-Neutralizing Antibodies in Infants
Catherine Kegakilwe Koofhethile †, Harvard School of Public Health
Viral Reservoirs and Immune Responses in Adolescents and Young Adults with HIV
Viral Reservoirs and Immune Responses in Adolescents and Young Adults with HIV
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Coffee Available
4:30–5:00 PM
B Cell Responses and Broadly-Neutralizing Antibodies: Trials and Tribulations (Joint)
5:00–7:00 PM
Marina F. Caskey, Rockefeller University
Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies
Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies
Paula M Cannon †, University of Southern California, Keck School of Medicine
In vivo B Cell Engineering
In vivo B Cell Engineering
William Schief †, The Scripps Research and IAVI
Combining Germline Targeting Approaches Across Diverse bNAb Epitopes
Combining Germline Targeting Approaches Across Diverse bNAb Epitopes
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Monday, January 5, 2026
Departure
12:00–11:59 PM
Subscribe for Updates